Tempest Therapeutics, Inc. — Form 8-K
Filed September 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
Tempest Therapeutics (market cap ~$30.1M) filed an 8-K on 2026-09-16 reporting Item 5.07 (shareholder vote submission) and Item 8.01 (other events). The filing text provided contains only document metadata and header information; the substantive details of what matters were submitted to a vote, vote results, or the nature of other events are not disclosed in the provided excerpts.
Why this rating
Filing structure routine; no material deal, financing, or operational detail disclosed in available text. Cannot assess substance without actual voting matter disclosures.
Extracted items
- 5.07 shareholder vote
- 8.01 other event
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.